People who tested positive for Covid-19 could be given a pill to help stop the disease.
Clinical trials of the flu drug favipiravir are underway in the UK – and a result is expected in six months.
The study’s lead investigator, Professor Kevin Blyth of the University of Glasgow, said, “It would be a big step forward if antiviral drugs worked.
“You don’t have hospital services that are under tremendous pressure because patients never come to the hospital.
“Normal services can work and you don’t have to put in lockdowns or other draconian controls.”
Favipiravir was reported to have been developed in Japan in 2014 The mirror.
The GETAFIX study measures whether Covid patients do not become more seriously ill.
If it is shown to work, millions of doses will be given out to the NHS.
Anyone in the Glasgow area can volunteer for the study as soon as symptoms appear. In a separate study, the same drug is also being tested on participants in London. Cases.
Prof. Blyth said, “Antivirals haven’t really decreased, but diseases like HIV show how effective they can be.”
Anyone who develops symptoms can volunteer to participate in the Glasgow Early Treatment Arm: Favipiravir (GETAFIX) study.